Login / Signup
Has the time come to assess small molecule/biologic drug combination for the management of moderate-to-severe hidradenitis suppurativa?
Carlo Alberto Maronese
John R Ingram
Angelo Valerio Marzano
Published in:
The British journal of dermatology (2023)
Keyphrases
</>
hidradenitis suppurativa
small molecule
rheumatoid arthritis
protein protein
high intensity
drug induced
early onset
adverse drug